OpenVSafe by OpenVAERS
Search V-safe

7NZ-33112-12517

3 vaccinations 1 coded response 2 check-ins 1 free-text entry 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
973 / OR
Registered
2022-04-16
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-11
    Dose 1 — Pfizer-BioNTech
  2. 2021-02-01
    Dose 2 — Pfizer-BioNTech
  3. 2022-04-16
    Registered in v-safe
  4. 2022-04-16
    Dose 3 — Pfizer-BioNTech
  5. 2022-04-16
    Health check-in — day 0, dose 3
    Feeling: Fair · Site: Pain · Fatigue or tiredness, Abdominal pain
    Adult check-in
  6. 2022-04-17
    Survey response — days 1–6 daily, dose 3
    MedDRA: Dizziness — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Diarrhea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Dizziness
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-01-11Pfizer-BioNTech No
22021-02-01Pfizer-BioNTech No
32022-04-16Pfizer-BioNTech No

Free text

Release 11 — days 1–6 daily, dose 3

2022-04-17

Systemic reaction (other): Dizziness

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SRODizziness · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…